She leads the Early Phase Clinical Trials Program in Pediatric Oncology and she is the UCSF Principal Investigator for the national Children’s Oncology Group Phase 1 & Pilot Consortium. Her research career is focused on the development of novel prognostic and predictive biomarkers and incorporation of these biomarkers into new clinical trials, working towards more effective and less toxic therapies in children and young adults with solid tumors.